Brief: Bio-Works Provides WorkBeads Protein A To Yumab In Early Clinical Testing Against COVID-19

Bio-Works Technologies AB

16/11/2020 08:14

Nov 16 (Reuters) - Bio-Works Technologies AB  BIOWKS.ST :
    * BIO-WORKS PROVIDES WORKBEADS PROTEIN A TO YUMAB FOR
SCREENING OF
ANTIBODY CANDIDATES NOW IN EARLY CLINICAL TESTING AGAINST
COVID-19
    * AS A RESPONSE TO COVID-19 OUTBREAK, CO OFFERED TO PROVIDE
RESINS
FOR VACCINE PURIFICATION RESEARCH
    * ONE SUCH PROJECT HAS NOW RESULTED IN A NEUTRALIZING
MONOCLONAL
ANTIBODY CANDIDATE AGAINST SARS-COV-2 BEING PRODUCED FOR
CLINICAL PHASE 1 TESTING

Source text for Eikon:  ID:nWkr2ZL14x 
Further company coverage:  BIOWKS.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))